Ain Holdings Inc.
【Ain Holdings】Notice of Appointment of Director Candidates｜June 25, 2026
Ain Holdings has decided on director candidates to be presented at the 57th Ordinary General Meeting of Shareholders scheduled for July 30, 2026, and Tomicco Tawaraki is scheduled to be appointed as a new director. Reappointment of existing directors is also announced.
Key Figures
- Number of director candidates: 7 (including 6 outside director candidates, 1 new candidate)
- New director candidate: Tomicco Tawaraki (born June 22, 1958)
- Outgoing director: Miya Oishi (Representative Director and Senior Managing Officer)
AI要約
Overview of Executive Personnel Changes
Ain Holdings has decided on the director candidates to be presented at the 57th Annual General Meeting of Shareholders scheduled for July 30, 2026. The new candidate, Tomicco Tawaraki, has a background in the Ministry of Health, Labour and Welfare, with experience in drug and medical device review and safety measures, and is scheduled to be appointed as an outside director. Reappointment of existing directors is also expected.
Future Plans and Impact
This executive personnel change aims to strengthen corporate governance and promote management leveraging experience in pharmaceuticals and medical devices. The new director candidate, Tomicco Tawaraki, is expected to contribute with her expertise in medical and regulatory fields to the company's strategic business management. Reappointment of current directors is expected to maintain management stability.
Ain Holdings
Company overview · Stock price · Financial data · All IR
